On May 2, 2025, Barclays analyst Matthew Bouley announced a revised price target for Builders FirstSource (BLDR, Financial). The new target price is set at $137.00 USD, down from the previous target of $151.00 USD. This adjustment reflects a percentage change of -9.27%.
Despite the lowered price target, Barclays has maintained its "Overweight" rating on Builders FirstSource (BLDR, Financial). The analyst's decision suggests continued confidence in the company's market potential, even though the target price has been adjusted downward.
Builders FirstSource (BLDR, Financial), a key player in the construction industry, continues to attract attention from analysts and investors alike. The revised price target and maintained "Overweight" rating highlight ongoing interest and scrutiny of the company's performance and future prospects.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 20 analysts, the average target price for Builders FirstSource Inc (BLDR, Financial) is $152.35 with a high estimate of $193.00 and a low estimate of $125.00. The average target implies an upside of 31.71% from the current price of $115.67. More detailed estimate data can be found on the Builders FirstSource Inc (BLDR) Forecast page.
Based on the consensus recommendation from 20 brokerage firms, Builders FirstSource Inc's (BLDR, Financial) average brokerage recommendation is currently 1.9, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Builders FirstSource Inc (BLDR, Financial) in one year is $142.84, suggesting a upside of 23.49% from the current price of $115.67. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Builders FirstSource Inc (BLDR) Summary page.
